Hereditary diseases and breast cancer are in the line if sight
Montreal, September 25th 2017 - BiogeniQ is pleased to announce that it now offers a genetic counselling service for patients with a personal or family history of cancer or genetic disease. Breast cancer prevention is one of their main aims. Through the use of genetic counselling, BiogeniQ is committed to assessing the risk of hereditary disease, the possible impact on the individual and his family, as well as the relevance of continuing with a genetic test. This approach can save time in the diagnosis and treatment of people considered at risk
BiogeniQ stands out through the simplicity and speed of direct access to a genetic counsellor. Indeed, counselling is available within a maximum of two weeks. During this encounter, a genetic counsellor from BiogeniQ can evaluate the hereditary risks of the patient and guide him or her, if necessary, toward the best choice of test among all those available from the BiogeniQ’s partner laboratories. Note that the majority of these tests require a simple saliva sample and offer results within two to four weeks.
Breast cancer, still too much devastation
When it comes to breast cancer, which will directly affect 1 woman out of 9 in the course of her life, counselling and genetic testing can make all the difference. In this particular case, genetic counselling will first distinguish women for who the risk of cancer is hereditary or not. Then, identifying genes associated with breast cancer, including BRCA1 and BRCA2, by testing becomes a turning point to determine measures for screening and reducing the risk of breast cancer or ovarian cancer. Thanks to genetic counselling, prevention makes more sense in acting faster and in an informed manner.
“Men and women who are carriers of a BRCA mutation have a high risk of certain types of cancer. Genetic counselling allows them to quickly identify risks and gives them the chance to make the best choice depending on their personal situation. For example, a 25-year-old woman at increased risk of ovarian cancer will perhaps choose increased screening while the 55-year-old woman may choose (oophorectomy) surgery.” - Nathalie Bolduc, genetic counsellor.
Be it for breast cancer or any other condition, BiogeniQ and their genetic counsellors work with family physicians and other specialists to provide all the support and guidance needed by the patient.
With this new service, BiogeniQ lets people quickly get their genetic information and to make informed decisions about their health and that of their children, while advocating a three-step approach: Assess, Understand and Act.
Acting proactively by offering advice and, if needed, genetic testing, would eliminate statistics such as:
- 1 in 9 women will develop breast cancer during her lifetime
- 1 in 69 women will develop ovarian cancer during her lifetime
- 1 in 2000 men will develop breast cancer during his lifetime
- 1 in 8 men will develop prostate cancer during his lifetime
- 5% to 10% of breast cancers are hereditary
- 10% to 15% of ovarian cancers are hereditary
- It is estimated that about 1 person in 200 (men and women) are carriers of a BRCA1 or BRCA2 mutation
Written genetic counselling & summary: $195 per 60-minute session.
Genetic testing & post-test counselling: Variable, depending on the disease and the required test. For breast cancer, from $605 to $895, depending on the test.
BiogeniQ helps people take control of their health by offering simple, appropriate, and relevant recommendations based on their DNA. Thanks to cooperation with other health professionals, genetic testing is delivered in a responsible and ethical way. Since its foundation in 2013, BiogeniQ has won many awards in the health field and in new technologies, including the Techno Startup of the Year from the Junior Chambers of Commerce of Quebec and Young Start-up Entrepreneur for its president, from the Montreal Junior Chamber of Commerce's Arista contest. For more information, see biogeniq.ca.